Are IL18RAP gene polymorphisms associated with body mass regulation? A cross-sectional study

Objectives To investigate the association between IL18RAP and body mass index (BMI) and obesity and to verify the effect of a polymorphism in the microRNA136 (MIR136) IL18RAP binding region. Design We analysed samples from two Spanish cross-sectional studies, VALCAR (Spanish Mediterranean coast) and Hortega (Spanish centre). These studies aimed at analysing cardiovascular risk and development of cardiovascular disease in the general population. Both populations correspond to regions with different characteristics. Setting Five IL18RAP single nucleotide polymorphisms were selected using the SYSNPs web tool and analysed by oligonucleotide ligation assay (SNPlex). For the MIR136 functional study, cells were transfected with plasmids containing different rs7559479 polymorphism alleles and analysed by luciferase reporter assays. Participants 1970 individuals (Caucasian, both genders): VALCAR (468) and Hortega (1502). Results rs2293225, rs2272127 and rs7559479 showed the following associations: rs7559479 G allele correlated with a higher obesity risk (P=0.01; OR=1.82; 95% CI 1.15 to 2.87 for the VALCAR group; P=0.033; OR=1.35; 95% CI 1.03 to 1.79 for the Hortega population) and higher body mass index (BMI) values (P=0.0045; P=0.1 for VALCAR and Hortega, respectively); a significant association with obesity (P=0.0024, OR=1.44, 95% CI 1.14 to 1.82) and increased BMI values (P=0.008) was found when considering both populations together. rs2293225 T allele was associated with lower obesity risk (P=0.036; OR=0.60; 95% CI 0.35 to 0.96) and lower BMI values (P=0.0038; OR=1.41) while the rs2272127 G allele was associated with lower obesity risk (P=0.028; OR=0.66; 95% CI 0.44 to 0.97) only in the VALCAR population. A reporter assay showed that the presence of the A allele in rs7559479 was associated with increased MIR136 binding to IL18RAP. Conclusions Our results suggest that polymorphisms in IL18RAP influence susceptibility to obesity. We demonstrated that the A allele in rs7559479 increases MIR136 binding, which regulates IL-18 system activity.

[1]  T. Kunej,et al.  Minimal Standards for Reporting microRNA:Target Interactions. , 2017, Omics : a journal of integrative biology.

[2]  R. Gomis,et al.  Hypothalamic miRNAs: emerging roles in energy balance control , 2015, Front. Neurosci..

[3]  Qiang Liu,et al.  MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1 , 2014, Diagnostic Pathology.

[4]  Qiang Yu,et al.  MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells , 2014, Journal of Neuro-Oncology.

[5]  H. Guan,et al.  Targeting Smad2 and Smad3 by miR-136 suppresses metastasis-associated traits of lung adenocarcinoma cells. , 2014, Oncology research.

[6]  C. Abraham,et al.  The IL18RAP Region Disease Polymorphism Decreases IL-18RAP/IL-18R1/IL-1R1 Expression and Signaling through Innate Receptor–Initiated Pathways , 2014, The Journal of Immunology.

[7]  C. Bouchard,et al.  Replication of 6 Obesity Genes in a Meta-Analysis of Genome-Wide Association Studies from Diverse Ancestries , 2014, PloS one.

[8]  E. Zorrilla,et al.  Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice , 2014, Brain, Behavior, and Immunity.

[9]  R. Cooper,et al.  Impact of obesity-related genes in Spanish population , 2013, BMC Genetics.

[10]  Joaquín Dopazo,et al.  Select Your SNPs (SYSNPs): a web tool for automatic and massive selection of SNPs , 2012, Int. J. Data Min. Bioinform..

[11]  J. Um,et al.  Association of interleukin-18 gene polymorphism with body mass index in women , 2012, Reproductive Biology and Endocrinology.

[12]  A. Kastrati,et al.  Interleukin 18 gene variation and risk of acute myocardial infarction. , 2011, Cytokine.

[13]  K. Huber,et al.  Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose , 2011, Wiener klinische Wochenschrift.

[14]  C. Dani,et al.  Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis , 2011, Genome Biology.

[15]  J. Timmons,et al.  Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity , 2011, BMC endocrine disorders.

[16]  F. Hu,et al.  Lean Body Mass, Interleukin 18, and Metabolic Syndrome in Apparently Healthy Chinese , 2011, PloS one.

[17]  L. Pastore,et al.  miR‐519d Overexpression Is Associated With Human Obesity , 2010, Obesity.

[18]  M. Mayr,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.

[19]  J. Brehm,et al.  Analyses of shared genetic factors between asthma and obesity in children. , 2010, The Journal of allergy and clinical immunology.

[20]  Federica Limana,et al.  Circulating microRNAs are new and sensitive biomarkers of myocardial infarction , 2010, European heart journal.

[21]  J. Moreno-Navarrete,et al.  MiRNA Expression Profile of Human Subcutaneous Adipose and during Adipocyte Differentiation , 2010, PloS one.

[22]  R. Loos,et al.  Recent progress in the genetics of common obesity. , 2009, British journal of clinical pharmacology.

[23]  Z. Dai,et al.  Intermittent High Glucose Stimulate MCP-l, IL-18, and PAI-1, but Inhibit Adiponectin Expression and Secretion in Adipocytes Dependent of ROS , 2009, Cell Biochemistry and Biophysics.

[24]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[25]  G. Sesti,et al.  IL-18 gene polymorphism and metabolic syndrome. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[26]  C. Darimont,et al.  Interleukin‐18 Protein Level Is Upregulated in Adipose Tissue of Obese Mice , 2009, Obesity.

[27]  M. Netea,et al.  Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus , 2008, International Journal of Obesity.

[28]  M. Czech,et al.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[29]  Jennifer Couzin,et al.  MicroRNAs Make Big Impression in Disease After Disease , 2008, Science.

[30]  E. Lambert,et al.  The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease. , 2007, European journal of endocrinology.

[31]  J. Helge,et al.  Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. , 2007, European journal of endocrinology.

[32]  E. Zorrilla,et al.  Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency , 2007, Proceedings of the National Academy of Sciences.

[33]  B. Saltin,et al.  Adipose Tissue Interleukin‐18 mRNA and Plasma Interleukin‐18: Effect of Obesity and Exercise , 2007, Obesity.

[34]  S. Malnick,et al.  The medical complications of obesity. , 2006, QJM : monthly journal of the Association of Physicians.

[35]  Shizuo Akira,et al.  Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance , 2006, Nature Medicine.

[36]  J. Jenkins,et al.  The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFα in human adipocytes , 2005 .

[37]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[38]  J. Beilby,et al.  Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[39]  H. Kolb,et al.  The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. , 2005, European journal of endocrinology.

[40]  J. Pinkney,et al.  Role of cytokines in regulating feeding behaviour. , 2004, Current drug targets.

[41]  M. Schwartz,et al.  Genetics and pathophysiology of human obesity. , 2003, Annual review of medicine.

[42]  Masaki Mishima,et al.  The structure and binding mode of interleukin-18 , 2003, Nature Structural Biology.

[43]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[44]  D. Giugliano,et al.  Weight loss reduces interleukin-18 levels in obese women. , 2002, The Journal of clinical endocrinology and metabolism.

[45]  J. Sims.  IL-1 and IL-18 receptors, and their extended family. , 2002, Current opinion in immunology.

[46]  CR Plata-Salamán.  Cytokines and feeding , 2001, International Journal of Obesity.

[47]  T. Tuschl,et al.  Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.

[48]  S. Swain,et al.  Interleukin 18 , 2001, The Journal of experimental medicine.

[49]  Michael G. Shields.  Translator's Introduction , 2001 .

[50]  I. McInnes,et al.  A proinflammatory role for IL-18 in rheumatoid arthritis. , 1999, The Journal of clinical investigation.

[51]  M. Prinz,et al.  Murine Microglial Cells Produce and Respond to Interleukin‐18 , 1999, Journal of neurochemistry.

[52]  T. Born,et al.  Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling* , 1998, The Journal of Biological Chemistry.

[53]  A. Enk,et al.  Production of functional IL‐18 by different subtypes of murine and human dendritic cells (DC): DC‐derived IL‐18 enhances IL‐12‐dependent Th1 development , 1998, European journal of immunology.

[54]  C. Moskaluk,et al.  IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. , 1998, Journal of immunology.

[55]  A. Enk,et al.  Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. , 1997, Journal of immunology.

[56]  H. Okamura,et al.  Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. , 1997, Journal of immunology.

[57]  H. Okamura,et al.  Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. , 1997 .

[58]  H. Okamura,et al.  Endotoxin-induced serum factor that stimulates gamma interferon production , 1989, Infection and immunity.

[59]  Jiaxiang Wang,et al.  Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A , 2013, Tumor Biology.

[60]  D. Strachan,et al.  Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture , 2013 .

[61]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[62]  John N Fain,et al.  Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. , 2006, Vitamins and hormones.

[63]  J. Jenkins,et al.  The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes. , 2005, Biochemical and biophysical research communications.